English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Nance-Horan Syndrome (NHS) was initially reported in 1974 by Walter E. Nance in the United States and Margaret B. Horan in Australia [1]. As a rare X-linked hereditary disorder, NHS is characterized by a constellation of ophthalmologic features, dental anomalies, facial dysmorphism, and intellectual delay [1,2]. With fewer than 70 NHS families described in the existing literature, the disease prevalence and incidence remain elusive. Mutations in the causative NHS gene, mapping to chromosome region Xp22.13, impair regulation of midbrain, retina, lens, tooth, and craniofacial development [1,4].

Antenatal diagnoses of congenital cataracts and related surgical complications in a familial case of Nance-Horan Syndrome